Mitral Regurgitation Clinical Trials in The Bronx, New York
4 studies are recruiting for mitral regurgitation in The Bronx, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Cephea Early Feasibility Study
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Montefiore Medical Center - Moses Campus, The Bronx, New York
- Locations
- 22 in total
- Run by
- Abbott Medical Devices
-
Abbott Cephea Mitral Valve Disease Registry
The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of co…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Montefiore Medical Center - Moses Campus, The Bronx, New York
- Locations
- 24 in total
- Run by
- Abbott Medical Devices
-
EFS of Posterior Leaflet Replacement to Reduce Mitral Regurgitation (United States)
The goal of this early feasibility clinical trial is to learn if the device MR-ace Implant and Delivery System works in patients with moderate or severe mitral valve regurgitation. It will also learn about the safety of the device MR-ace Implant and Delivery System. The main questions it aims to an…
- Stage
- Not phased
- Ages
- 21 and older
- Site
- Montefiore Medical Center, The Bronx, New York
- Locations
- 3 in total
- Run by
- Polares Medical SA
-
ATLAS (AltaValve) Pivotal Trial
This is a prospective, single arm, multicenter, clinical trial designed to evaluate the safety and performance of the AltaValve System for the treatment of mitral regurgitation in a targeted patient population.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Montefiore Medical Center, The Bronx, New York
- Locations
- 58 in total
- Run by
- 4C Medical Technologies, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.